A detailed history of Avestar Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Avestar Capital, LLC holds 2,943 shares of EW stock, worth $192,707. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,943
Previous 2,520 16.79%
Holding current value
$192,707
Previous $240,000 12.92%
% of portfolio
0.03%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $35,658 - $39,893
423 Added 16.79%
2,943 $271,000
Q1 2024

May 10, 2024

BUY
$72.54 - $95.56 $182,800 - $240,811
2,520 New
2,520 $240,000
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $1,723 - $2,112
-28 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$45.7 - $58.03 $137 - $174
3 Added 12.0%
28 $4,000
Q2 2018

Aug 10, 2018

BUY
$42.45 - $51.3 $169 - $205
4 Added 19.05%
25 $1,000
Q1 2018

May 10, 2018

BUY
$37.19 - $47.45 $557 - $711
15 Added 250.0%
21 $1,000
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $202 - $236
6
6 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.